Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma

Published:2013-06 Issue:6 Volume:49 Page:620-625
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Hsu Cheng-Lung,Chan Sheng-Chieh,Chang Kai-Ping,Lin Tung-Liang,Lin Chien-Yu,Hsieh Chia-Hsun,Huang Shiang-Fu,Tsang Ngan-Ming,Lee Li-Yu,Ng Shu-Hang,Wang Hung-Ming

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference31 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma;Lin;Head Neck,2003

3. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival;Lin;J Clin Oncol,2003

4. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients;Kam;J Clin Oncol,2007

5. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?;Teo;Int J Radiat Oncol Biol Phys,1998

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2024-05-11

2. Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection;Infectious Agents and Cancer;2024-03-14

3. The Clinical Application of Plasma EBV DNA Assay in NPC;Medical Radiology;2023

4. Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study;Cancer Cell International;2022-10-31

5. Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA;BMC Cancer;2022-08-05